These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22042237)

  • 1. Anti-inflammatory activity of chondroitin sulphate: new functions from an old natural macromolecule.
    Volpi N
    Inflammopharmacology; 2011 Dec; 19(6):299-306. PubMed ID: 22042237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory activity of chondroitin sulfate.
    Iovu M; Dumais G; du Souich P
    Osteoarthritis Cartilage; 2008; 16 Suppl 3():S14-8. PubMed ID: 18667340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of inflammation by chondroitin sulfate.
    Vallières M; du Souich P
    Osteoarthritis Cartilage; 2010 Jun; 18 Suppl 1():S1-6. PubMed ID: 20399900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory and anti-inflammatory effects of chondroitin sulphate.
    du Souich P; García AG; Vergés J; Montell E
    J Cell Mol Med; 2009 Aug; 13(8A):1451-63. PubMed ID: 19522843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical review of chondroitin sulfate in osteoarthritis.
    Uebelhart D
    Osteoarthritis Cartilage; 2008; 16 Suppl 3():S19-21. PubMed ID: 18674931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis.
    Herrero-Beaumont G; Marcos ME; Sánchez-Pernaute O; Granados R; Ortega L; Montell E; Vergés J; Egido J; Largo R
    Br J Pharmacol; 2008 Jun; 154(4):843-51. PubMed ID: 18536737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondroitin sulphate for symptomatic osteoarthritis: critical appraisal of meta-analyses.
    Monfort J; Martel-Pelletier J; Pelletier JP
    Curr Med Res Opin; 2008 May; 24(5):1303-8. PubMed ID: 18416884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathobiology of osteoarthritis and the rationale for using the chondroitin sulfate for its treatment.
    Volpi N
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun; 4(2):119-27. PubMed ID: 15180452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chondroprotective effects of the combination chondroitin sulfate-glucosamine in a model of osteoarthritis induced by anterior cruciate ligament transection in ovariectomised rats.
    Terencio MC; Ferrándiz ML; Carceller MC; Ruhí R; Dalmau P; Vergés J; Montell E; Torrent A; Alcaraz MJ
    Biomed Pharmacother; 2016 Apr; 79():120-8. PubMed ID: 27044820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Condrosulf®: structural characterization, pharmacological activities and mechanism of action.
    Volpi N
    Curr Med Chem; 2014; 21(34):3949-61. PubMed ID: 25245376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chondroitin sulfate in the pathophysiology of the osteoarthritic joint: a narrative review.
    Martel-Pelletier J; Kwan Tat S; Pelletier JP
    Osteoarthritis Cartilage; 2010 Jun; 18 Suppl 1():S7-11. PubMed ID: 20399897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential antipsoriatic effect of chondroitin sulfate through inhibition of NF-κB and STAT3 in human keratinocytes.
    Andrés RM; Payá M; Montesinos MC; Ubeda A; Navalón P; Herrero M; Vergés J; Terencio MC
    Pharmacol Res; 2013 Apr; 70(1):20-6. PubMed ID: 23276728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chondroitin sulphate: a complex molecule with potential impacts on a wide range of biological systems.
    Lauder RM
    Complement Ther Med; 2009 Jan; 17(1):56-62. PubMed ID: 19114230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chondroitin sulphate inhibits NF-κB activity induced by interaction of pathogenic and damage associated molecules.
    Stabler TV; Huang Z; Montell E; Vergés J; Kraus VB
    Osteoarthritis Cartilage; 2017 Jan; 25(1):166-174. PubMed ID: 27614315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nonanimal high- and low-molecular-mass chondroitin sulfates produced by a biotechnological process in an animal model of polyarthritis.
    Bauerova K; Ponist S; Kuncirova V; Drafi F; Mihalova D; Paulovicova E; Volpi N
    Pharmacology; 2014; 94(3-4):109-14. PubMed ID: 25247259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of pharmaceutical composition and evidence from clinical trials and pharmacological studies in determining effectiveness of chondroitin sulphate and other glycosaminoglycans: a critique.
    Rainsford KD
    J Pharm Pharmacol; 2009 Oct; 61(10):1263-70. PubMed ID: 19814857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of experimental accelerated atherosclerosis by chondroitin sulphate.
    Martínez-Calatrava MJ; Largo R; Herrero-Beaumont G
    Osteoarthritis Cartilage; 2010 Jun; 18 Suppl 1():S12-6. PubMed ID: 20399896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what's the evidence?
    Hochberg M; Chevalier X; Henrotin Y; Hunter DJ; Uebelhart D
    Curr Med Res Opin; 2013 Mar; 29(3):259-67. PubMed ID: 23186102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of different chondroitin sulfate preparations in relation to their therapeutic activity.
    Volpi N
    J Pharm Pharmacol; 2009 Oct; 61(10):1271-80. PubMed ID: 19814858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glucosamine hydrochloride and chondroitin sulphate, alone and in combination, on normal and interleukin-1 conditioned equine articular cartilage explant metabolism.
    Dechant JE; Baxter GM; Frisbie DD; Trotter GW; McIlwraith CW
    Equine Vet J; 2005 May; 37(3):227-31. PubMed ID: 15892231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.